|
|
|
June 14, 2010
Roxro Pharma Inc. Announced the Approval by the FDA of SPRIX™, Intranasal Ketorolac
March 2, 2010
Shionogi Enters Into Exclusive License Agreement with Quatrx Pharmaceuticals to Market Ospemifene
September 10, 2009
Abbott Announces Acquisition of Evalve
September 10, 2009
QuatRx Pharmaceuticals Reports Positive Ophena Pivotal Phase III Results
July 28, 2009
Akebia Completes $16M Expansion of Series A Financing
April 22, 2009
Hansen Medical Announces Closing Of Public Offering Of Common Stock
April 14, 2009
ViewRay Incorporated Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG
February 6, 2009
FDA Accepts ROX-888 NDA
November 24, 2008
TranS1 Procedure Featured on World News Tonight
July 30, 2008
CVRx Announces $84 Million Series E Financing
May 13, 2008
BMS and KAI Enter Global Alliance to Develop and Commercialize KAI-9803 for Cardiovascular Disease
March 28, 2008
Series A Financing Funds Spinout of TriVascular from Boston Scientific
January 29, 2008
QuatRx Pharmaceuticals Reports Positive Sobetirome Phase I Results
January 21, 2008
ViewRay Completes Series B Financing
January 20, 2008
Bausch & Lomb to Buy eyeonics
January 3, 2008
QuatRx Pharmaceuticals Reports Positive Phase III Results
December 4, 2007
Evalve Completes Series D Financing
October 31, 2007
CVRx Receives CE Mark Approval
October 17, 2007
TranS1 Goes Public
September 21, 2007
Emphasys Medical Files Registration Statement for IPO
July 27, 2007
eyeonics Files Registration Statement for IPO
July 24, 2007
TranS1 Files for IPO of Up To $80.5 Million
May 22, 2007
QuatRx Pharmaceuticals Closes $44 Financing
May 9, 2007
CVRx Announces $65 Million Series D Financing
May 3, 2007
Hansen Medical Receives FDA
Approval
April 30, 2007
Hansen Medical Enters Joint
Development and Co-Marketing Agreement with St. Jude Medical
April 13, 2007
eyeonics' Sales Increase 36% and Records Profitable Quarter
March 26, 2007
Evalve's Percutaneous MitraClip™ Device Results in Significant Reverse Left Ventricular Remodeling
March 25, 2007
KAI Pharmaceuticals Presents
Promising Phase 1/2 Results for KAI-9803 in Reperfusion
Injury
January 8, 2007
QuatRx Pharmaceuticals Reports
Positive Results from Phase II Trial of Fispemifene
November 20, 2006
Actelion Announces Definitive
Agreement to Acquire CoTherix for $420 Million
November 16, 2006
Hansen Medical Goes Public
November 15, 2006
TranS1's AxiaLIF™ Honored as Most Promising New Product in 2006
November 14, 2006
Clinical Trial Findings Show Significant Reduction in Blood Pressure with CVRx Rheos™ Baroreflex Hypertension Therapy™ System
October 16, 2006
CVRx Receives IDE Approval for Rheos™ Baroreflex Hypertension Therapy™ System Pivotal Trial
October 9, 2006
eyeonics product recognized in article on next generation of intraocular lens
September 29, 2006
Aspreva Announces Achievement
of Targeted Patient Enrollment in Phase III Clinical Trial
for CellCept in Lupus Nephritis
September 29, 2006
SpinalMotion Raises $20 Million to Drive Cervical and Lumbar Trial
September 19, 2006
QuatRx Pharmaceuticals Announces Rochelle Hanley Joining QuatRx as Chief Medical Officer
September 18, 2006
CVRx Appoints Nadim Yared President and CEO
August 22, 2006
Theravance Announces Positive Results in Phase 3 Telavancin Complicated Skin and Skin Structure Infection Program
August 16, 2006
Hansen Medical files for $86 million IPO
July 24, 2006
eyeonics reports continued robust
revenue traction for its innovative product, crystalens
July 17, 2006
Emphasys reports raising additional
capital to further the development of its lead product,
Zephyr
June 20, 2006
Rib-X announces raising a $50
million Series C financing to further the development
of its antibiotic product candidates
May 17, 2006
Hansen reports data suggesting
that improved catheter control does not come at increased
time, cost, or safety
May 11, 2006
CVRx raises $30 million, which will allow the company to continue accumulating clinical data to demonstrate the efficacy of their device
May 2, 2006
KAI Pharmaceuticals Completes
$35 Million Series B Financing
January 9, 2006
KAI Pharmaceuticals, Inc. and Sankyo Company, Limited enter a global alliance to develop and commercialize novel compounds for cardiovascular disease
November 17, 2005
Hansen Medical Secures $30 Million in Series C Financing
September 20, 2005
TranS1 announces $25.7 Million Series C financing
April 27, 2005
SpinalMotion Receives FDA Approval to Launch Clinical Studies Evaluating Lumbar and Cervical Artificial Disc Implants; Secures $20 million in Series B Funding
March 03, 2005
Aspreva Pharmaceuticals Announces
Pricing of Initial Public Offering at US$11.00 (C$13.68)
per share
December 13, 2004
QuatRx Pharmaceuticals raises $31 Million in third private equity financing
October 15, 2004
CoTherix, Inc. Announces Initial Public Offering of 5,000,000 Shares of Common Stock at $6.00 Per Share
|
|
| |
